Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/18650

Título:	Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Autor/a:	Burroughs, Andrew K.; Groszmann, Roberto J.; Bosch i Genover, Jaume; Grace, N.; Garcia-Tsao, G.; Patch, D.; García Pagán, Juan Carlos; Dagher, L.
Otros autores:	Universitat de Barcelona
Abstract:	Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therapeutic evaluation of antiviral therapy in chronic hepatitis C. It is a validated technique which is safe, well tolerated, well established, and reproducible. Serial HVPG measurements may be the best way to evaluate response to therapy in chronic hepatitis C.
Materia(s):	-Hepatitis C -Virosi -Pressió venosa -Hepatitis C -Virus diseases -Venous pressure
Derechos:	(c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2002
Tipo de documento:	Artículo Artículo - Versión publicada
Editor:	BMJ Group
Compartir:

Mostrar el registro completo del ítem